Yet, some patients may not want to stay on injectable versions of GLP-1 weight loss drugs, such as semaglutide and tirzepatide, long term
What is accelerating GLP-1 Telehealth Platforms Market adoption, and what is holding it back
Formulations: While most commercial GLP-1 medications are injectables, some compounded versions offer alternative forms like oral capsules, depending on patient preference
One literature review published in JAMA in April 2025 by a group of Irish researchers stated that GLP-1 drugs are known to reduce inflammation, improve insulin signaling, and promote neurogenesis, all of which could protect against cognitive decline. These potential benefits could also have an effect on cancer outcomes
Evaluating the Effects of the Novel GLP-1 Analogue Liraglutide in Alzheimers Disease: Study Protocol for a Randomised Controlled Trial (ELAD Study). Trials, vol
Other GLP-1 Pills in the Pipeline Although Wegovy is the first GLP-1 pill the FDA has approved for weight management, drug manufacturers are funding trials for additional oral GLP-1 medications
